Stephen L Sabba

CIK 1442372 · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.25M

Companies

3

Total Filings

44

Lifetime Open-Market Net

-$6.14M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LGND Director 33,629 $255.54 $8.59M -$6.14M 35 2026-06-09
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director $0 2 2018-08-13
QLTI Director 24,500 $26.82 $657.1K $0 7 2016-06-21

Recent Filings · Page 2 of 5

44 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-14 LGND Grant (A) +1,004 $0 EDGAR
2021-06-08 LGND Grant (A) +630 $0 EDGAR
2021-02-11 LGND Mixed -$2.89M EDGAR
2020-06-12 LGND Grant (A) +831 $0 EDGAR
2019-08-01 LGND Sell (S) −4,091 -$386.4K EDGAR
2019-06-10 LGND Grant (A) +835 $0 EDGAR
2018-09-06 LGND Mixed -$1.21M EDGAR
2018-08-13 NOVELION THERAPEUTICS INC. (NVLN) Delisted Grant (A) $0 EDGAR
2018-07-03 LGND Grant (A) +493 $0 EDGAR
2018-06-21 LGND Grant (A) +493 $0 EDGAR
Showing 1120 of 44
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.